Royal Philips has introduced a new compact positive airway pressure (PAP) device DreamStation Go for patients with obstructive sleep apnoea (OSA).
Developed to provide ease during travel, DreamStation Go is half the size of its predecessors in the firm's Dream Family range of products for sleep apnea.
The new sleep therapy device is claimed to possess performance, comfort and reliability similar to the comparatively bigger devices.
DreamStation Go features a discreet and slim-profile, weighs less than 2lb and has a built-in power supply, decreasing the number of components in the pack.
It also includes Philips' new 12mm micro-flexible tubing to reduce the volume, mobility and comfort.
Philips OSA patient and sleep therapy business leader Mark D'Angelo said: "Travelling with a sleep therapy device can be a cumbersome experience for patients with obstructive sleep apnoea.
"We designed the DreamStation Go as a holistic system with compact features and proven performance to help eliminate the need to sacrifice reliable therapy for convenience when travelling and vice versa, allowing for the best possible night's sleep no matter where it happens."
Both the fixed-pressure continuous positive airway pressure (CPAP) or auto-titrated APAP versions of the device include Bluetooth for facilitating data transmission to the firm's cloud-based patient management systems EncoreAnywhere and Care Orchestrator.
When combined with Philip's DreamMapper application, the device allows users to keep track of therapy adherence across multiple devices from a single platform.
The device is deemed suitable for in-flight use as it meets the Federal Aviation Administration (FAA) standards.
It is currently available at select online retailers in the US, with plans for further expansion to other markets later this year.
Image: Philips’ on-the-go device DreamStation Go. Photo: courtesy of PRNewsFoto/Royal Philips.